1.
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
by Ettehad, Dena, MSc
The Lancet (British edition), 2015, Vol.387 (10022), p.957-967
2.
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis
by Xie, Xinfang, MD
The Lancet (British edition), 2016, Vol.387 (10017), p.435-443
3.
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
by Jun, Min, MSc
The Lancet (British edition), 2010, Vol.375 (9729), p.1875-1884
4.
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review
by Chow, Clara K, Prof
The Lancet (British edition), 2017, Vol.389 (10073), p.1035-1042
5.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
by Zoungas, Sophia
Diabetologia, 2014-09-17, Vol.57 (12), p.2465-2474
6.
Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
by Welsh, Paul
Diabetologia, 2018-05-04, Vol.61 (7), p.1581-1591
7.
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
by Fox, Caroline S, MD
The Lancet (British edition), 2012, Vol.380 (9854), p.1662-1673
8.
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study
by Oshima, Megumi
Diabetologia, 2019-07-13, Vol.62 (11), p.1988-1997
9.
10.
Older age is a strong predictor for poor outcome in intracerebral haemorrhage: the INTERACT2 study
by Rådholm, Karin
Age and ageing, 2015-05, Vol.44 (3), p.422-427
11.
Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
by van der Leeuw, Joep
Diabetologia, 2016-12, Vol.59 (12), p.2603–2612-2612
12.
Injury in elite New Zealand cricketers 2002–2008: descriptive epidemiology
by Frost, Warren Leonard
British journal of sports medicine, 2014-06, Vol.48 (12), p.1002-1007
13.
Practice Patterns for Neurosurgical Utilization and Outcome in Acute Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trials 1 and 2 Studie...
by Guo, Rui
Neurosurgery, 2017-12-01, Vol.81 (6), p.980-985
14.
Trials on blood pressure–lowering and secondary stroke prevention
by Chalmers, John
The American journal of cardiology, 2003, Vol.91 (10), p.3-8
15.
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial
by Arima, Hisatomi
Journal of neurology, neurosurgery and psychiatry, 2014-11, Vol.85 (11), p.1284-1285
16.
Determinants and Prognostic Significance of Hematoma Sedimentation Levels in Acute Intracerebral Hemorrhage
by Sato, Shoichiro
Cerebrovascular diseases (Basel, Switzerland), 2016-02, Vol.41 (1-2), p.80-86
17.
Higher mortality in patients with right hemispheric intracerebral haemorrhage: INTERACT1 and 2
by Sato, Shoichiro
Journal of neurology, neurosurgery and psychiatry, 2015-12, Vol.86 (12), p.1319-1323
18.
Systematic Risk and the Muni Puzzle
by Chalmers, John M.R
National tax journal, 2006-12-01, Vol.59 (4), p.833-848
19.
Withdrawal of active treatment after intracerebral haemorrhage in the INTERACT2 study
by Muñoz Venturelli, Paula
Age and ageing, 2017-03-01, Vol.46 (2), p.329-332
20.
Off-Hour Admission and Outcomes in Patients with Acute Intracerebral Hemorrhage in the INTERACT2 Trial
by Sato, Shoichiro
Cerebrovascular diseases (Basel, Switzerland), 2015-09, Vol.40 (3-4), p.114-120
